In addition, the CSN functions in conjunction with the myelocytomatosis oncogene (MYC) to modulate the transcription of many MYC target genes, such as Ccnd2 and E2f1, which are reactivated in breast cancer metastasis to promote cell proliferation, invasion, and angiogenesis [156,157]. The gene discussed is MYC; the disease is breast cancer.